Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Kedudukan dalam Saham #20516
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Harga Saham
$20.27
Modal Pasaran
$128.37M
Perubahan (1 hari)
-1.37%
Perubahan (1 tahun)
79.91%
Negara
PL
Perdagangan Captor Therapeutics Spolka Akcyjna (CTX)

Kategori

Sejarah pecahan saham untuk Captor Therapeutics Spolka Akcyjna (CTX)
Saham Captor Therapeutics Spolka Akcyjna (simbol: CTX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 24, 2026.
Satu saham CTX yang dibeli sebelum Aug 24, 2026 kini bersamaan dengan 0 saham CTX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH